// App-Quantinova.ai

: Genetically-proxied low density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations

Researchers

Presenter

  • Maddalena Ardissino

Principal Investigators

  • Eric AW Slob

  • Rohin K Reddy

  • Alec P Morley

  • Phoebe Hill

  • Catherine Williamson

  • Antonio de Marvao

  • Fu Siong Ng

Medical Centers

  • National Heart and Lung Institute, Imperial College London, UK

  • Medical Research Council, London Institute of Medical Sciences, Imperial College London UK

  • Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK

  • Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, The Netherlands

  • Department of Medicine, School of Clinical Medicine, University of Cambridge, UK

  • Erasmus University Rotterdam Institute for Behavior and Biology, Erasmus University Rotterdam, The Netherlands

  • MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, UK

  • British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine and Sciences, King’s College London, London, UK

  • Royal Papworth Hospital, Cambridge Biomedical Campus, UK

  • Department of Women and Children’s Health, King’s College London, London, UK

Locations

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Anorectal Cream

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved